Detalhe da pesquisa
1.
Progressive Multifocal Leukoencephalopathy Treated by Immune Checkpoint Inhibitors.
Ann Neurol
; 93(2): 257-270, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36151879
2.
A genome-wide association study in autoimmune neurological syndromes with anti-GAD65 autoantibodies.
Brain
; 146(3): 977-990, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35348614
3.
Molecular predictors for decitabine efficacy in meningiomas - a pilot study.
J Neurooncol
; 164(1): 97-105, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37477823
4.
Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses.
J Neurooncol
; 164(3): 607-616, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37728779
5.
Confounders of intraoperative frozen section pathology during glioma surgery.
Neurosurg Rev
; 46(1): 286, 2023 Oct 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37891361
6.
Prognosis and histology of sporadic synchronous and metachronous meningiomas and comparative analyses with singular lesions.
Neurosurg Rev
; 46(1): 55, 2023 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36781550
7.
Iatrogenic lumbosacral infiltration with petroleum (hydrodesulfurized heavy) with secondary intrathecal distribution-a case report.
Acta Neurochir (Wien)
; 165(5): 1141-1144, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36735094
8.
Expression of decitabine-targeted oncogenes in meningiomas in vivo.
Neurosurg Rev
; 45(4): 2767-2775, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35445910
9.
The applicability of established clinical and histopathological risk factors for tumor recurrence during long-term postoperative care in meningioma patients.
Neurosurg Rev
; 45(2): 1635-1643, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34802073
10.
MGMT promoter methylation analysis for allocating combined CCNU/TMZ chemotherapy: Lessons learned from the CeTeG/NOA-09 trial.
Int J Cancer
; 148(7): 1695-1707, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33113214
11.
Diagnostic impact of additional O-(2-[18F]fluoroethyl)-L-tyrosine (18F-FET) PET following immunotherapy with dendritic cell vaccination in glioblastoma patients.
Br J Neurosurg
; 35(6): 736-742, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31407920
12.
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial.
Lancet
; 393(10172): 678-688, 2019 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30782343
13.
Initial experience with [18F]DPA-714 TSPO-PET to image inflammation in primary angiitis of the central nervous system.
Eur J Nucl Med Mol Imaging
; 47(9): 2131-2141, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31960097
14.
Neurocognitive functioning and health-related quality of life in adult medulloblastoma patients: long-term outcomes of the NOA-07 study.
J Neurooncol
; 148(1): 117-130, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32367436
15.
Human CCR5high effector memory cells perform CNS parenchymal immune surveillance via GZMK-mediated transendothelial diapedesis.
Brain
; 142(11): 3411-3427, 2019 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31563951
16.
Brain invasion in meningiomas: does surgical sampling impact specimen characteristics and histology?
Neurosurg Rev
; 43(2): 793-800, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31161444
17.
Multimodal Molecular Imaging of the Tumour Microenvironment.
Adv Exp Med Biol
; 1225: 71-87, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32030648
18.
Health-related quality of life and neurocognitive functioning with lomustine-temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial.
Lancet Oncol
; 20(10): 1444-1453, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31488360
19.
Combined intracavitary thermotherapy with iron oxide nanoparticles and radiotherapy as local treatment modality in recurrent glioblastoma patients.
J Neurooncol
; 141(1): 83-94, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30506500
20.
Fulminant MS Reactivation Following Combined Fingolimod Cessation and Yellow Fever Vaccination.
Int J Mol Sci
; 20(23)2019 Nov 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-31795084